AlphaQuest’s NeoGenomics NEO Stock Holding History

AlphaQuest’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28,816	Closed	-$339K	–	1323
2025 Q4	$339K	Buy	28,816 +28,815	+2,881,500%	+$311K	0.02%	1123
2025 Q3	$8	Sell	1 -26,502	-100%	-$186K	﹤0.01%	2236
2025 Q2	$194K	Buy	26,503 +20,158	+318%	+$163K	0.02%	1150
2025 Q1	$60.2K	Buy	+6,345	New	+$79.2K	0.01%	1472
2024 Q4	–	Sell	-1,542	Closed	-$22.7K	–	1913
2024 Q3	$22.7K	Sell	1,542 -4,382	-74%	-$68.6K	﹤0.01%	1497
2024 Q2	$82.2K	Sell	5,924 -15,659	-73%	-$222K	0.01%	978
2024 Q1	$339K	Buy	+21,583	New	+$333K	0.06%	486

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

AlphaQuest's NEO Position: Q1 2026 in Review

AlphaQuest sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 28,816 shares — an estimated $339K sold.

AlphaQuest first reported a position in NEO in Q1 2024 and held it in 7 quarters. The position peaked at $339K in Q1 2024. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

AlphaQuest reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 28,816 NeoGenomics shares in Q1 2026, an estimated $339K.
AlphaQuest first reported a position in NeoGenomics in Q1 2024 and held it in 7 quarters.
AlphaQuest's NeoGenomics position peaked at $339K in Q1 2024.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.